GHK-Cu and AHK-Cu: copper, color and identity

A simple mixture retains distinct components. In a coordination complex, bonds connect the metal ion with donor atoms of a ligand, producing a chemical species with its own geometry and spectroscopic behavior. In solution, the species present still depend on conditions and equilibria; the declared name alone does not establish the entire sample’s composition.

The catalog describes GHK-Cu as the copper(II) complex of glycyl-L-histidyl-L-lysine, sequence Gly-His-Lys, with CAS 89030-95-5 assigned to the complex rather than the free tripeptide. AHK-Cu is the corresponding Ala-His-Lys complex.

This adds questions for characterization. Alongside peptide identity and its proportion in the material, a copper–peptide assessment must determine whether copper is present and whether evidence supports coordination rather than unbound copper accompanying the peptide.

The GHK–copper(II) complex in solution was examined using optical spectroscopy, electron paramagnetic resonance and electron spin echo. At neutral pH, the study described a mononuclear 1:1 species with an EPR spectrum consistent with equatorial coordination by two or three nitrogen atoms, including one from histidine’s imidazole ring.

A later equilibrium study compared GHK with two synthetic analogs in which histidine was substituted, combining potentiometry, solution calorimetry, UV–visible spectroscopy, circular dichroism and EPR. It described different stoichiometries and stabilities and placed participation of lysine’s side-chain amino group at alkaline pH; at physiological pH that group was protonated.

A computational study investigated copper binding using ligand-field molecular mechanics, density functional theory and semiempirical methods. It described equatorial coordination by three nitrogens and one oxygen retained along the simulated trajectory, with a more mobile fifth apical position from the C-terminal carboxylate. Together, these works show why geometry and pH-dependent speciation matter; their experimental and computational findings should not be treated as interchangeable measurements.

Copper(II) color is associated with the metal’s d electrons and their coordination environment, rather than a peptide dye. Donor atoms split the d-orbital energy levels; absorption in the visible region can leave the transmitted or reflected complementary appearance in the blue-to-cyan range.

Color therefore carries information about the metal environment. Changing the coordination sphere can change level separations and the spectrum. The GHK-Cu solution study followed optical changes during pH titration and associated transitions with different species.

The catalog lists blue-to-deep-blue appearance for GHK-Cu and blue appearance for AHK-Cu, alongside an intact lyophilized cake and no visible foreign matter. A change in appearance warrants investigation against the specification. Visual color loss is not merely cosmetic, but it also cannot, by itself, identify the chemical change or prove its cause.

Both sequences contain histidine–lysine and differ at the first residue: glycine in GHK, alanine in AHK, adding a methyl substituent at the alpha carbon. The terminal amino group and histidine imidazole donor motif remain, helping explain their shared copper–peptide chemistry and blue appearance.

Their research histories are not equal in size or directly interchangeable. The cited GHK equilibrium study substituted histidine, not the first residue. Its interpretation of first-residue control and the importance of lysine’s available side chain must therefore be read within the actual analogs studied before extrapolating to AHK.

The cited AHK-Cu work used in vitro and ex vivo human hair follicle and dermal papilla cell models. It measured follicle elongation, cell proliferation, annexin V labeling by flow cytometry and the Bcl-2/Bax ratio. That is a defined experimental model, not a general clinical demonstration. Shared chemistry does not give the compounds identical evidence histories.

Inductively coupled plasma mass spectrometry is destructive. In a typical digested-sample workflow, the material is nebulized into an argon plasma that atomizes and ionizes it; the analyzer then separates ions by mass-to-charge ratio to measure elemental signals.

This explains both its purpose and its limit. It can determine which elements are present and quantify them using an appropriate method. It does not retain evidence of whether copper was coordinated to the peptide before digestion or which peptide accompanied it. Copper salt and copper–peptide material can produce the same elemental copper measurement.

Elemental analysis can evaluate both the declared metal and selected undeclared elements. A comparative review of pharmaceutical elemental-impurity methods discusses atomic absorption, ICP-OES, ICP-MS and X-ray fluorescence in relation to pharmacopeial and guideline requirements. ICP-MS offers high sensitivity, but fitness for a particular purpose still depends on the matrix, analytes and validated method.

The catalog’s analytical specification identifies copper assessment by ICP-MS or ICP-OES. A specification describes the requested test; a batch-specific result must be checked in the actual corresponding certificate and cannot be inferred from the catalog field alone.

A copper–peptide analytical panel should separate questions that no single result can answer. Read the requested tests and available batch results together rather than allowing one favorable signal to substitute for the entire characterization.

Blue color is an initial appearance observation, not sufficient proof of identity. Many aqueous copper(II) salts are also blue, so color alone cannot distinguish a formed complex from copper accompanying a peptide. Elemental results and appropriately interpreted coordination-sensitive measurements address different parts of that gap.

The visual comparison becomes even less direct in mixtures. The catalog describes GLOW as GHK-Cu with BPC-157 and thymosin beta-4, while KLOW adds KPV. Copper–peptide is one component among several, and their listed lyophilized appearance is pale blue rather than deep blue. Comparing color intensity with a GHK-Cu-only vial does not establish either product’s quality.

For handling, follow the current compound documentation: the cited catalog conditions specify sealed storage at −20 °C, protected from light and moisture, and list solubility in sterile water. Record observed appearance during preparation alongside the other traceability fields. An appearance note is useful evidence of handling history, but does not certify the solution’s identity or stability.